Quick Answer
Nutex Health Inc. reported Long Term Debt of $29.17 million for the year ending 2025.
- Nutex Health Inc. showed an increase of +29.9% in Long Term Debt from 2024 to 2025.
- This data is from Nutex Health Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: $16.31 million | Q3 2022: $24.69 million | Q1 2023: $25.11 million | Q2 2023: $25.11 million | Q3 2023: $19.30 million | Q1 2024: $26.31 million | Q2 2024: $22.41 million | Q3 2024: $26.80 million | Q1 2025: $21.73 million | Q2 2025: $20.46 million | Q3 2025: $25.57 million.
- Over the full 5 years of available data (2021 to 2025), Nutex Health Inc.'s Long Term Debt has declined by 63.0%.
- Historical annual values: Fiscal year 2025: $29.17 million | Fiscal year 2024: $22.47 million | Fiscal year 2023: $26.31 million | Fiscal year 2022: $23.05 million | Fiscal year 2021: $78.82 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: